Sage Rhino Capital LLC Novo Nordisk A S Transaction History

Sage Rhino Capital LLC

$446 Million
Q4 2024

A detailed history of Sage Rhino Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sage Rhino Capital LLC holds 12,091 shares of NVO stock, worth $1.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

12,091

Previous 12,385 2.37%

Holding current value

$1.1 Million

Previous $1.47 Million 29.44%

% of portfolio

0.23%

Previous 0.34%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$85.0 - $120.04 $24,990 - $35,291	-294 Reduced 2.37%	12,091 $1.04 Million
Q3 2024 Nov 01, 2024	BUY	$119.07 - $145.42 $6,548 - $7,998	55 Added 0.45%	12,385 $1.47 Million
Q2 2024 Jul 30, 2024	BUY	$122.71 - $146.91 $1,227 - $1,469	10 Added 0.08%	12,330 $1.76 Million
Q1 2024 Apr 26, 2024	BUY	$102.11 - $135.92 $9,087 - $12,096	89 Added 0.73%	12,320 $1.58 Million
Q4 2023 Feb 05, 2024	BUY	$87.78 - $105.45 $6,232 - $7,486	71 Added 0.58%	12,231 $1.27 Million
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $560,190 - $1.23 Million	6,160 Added 102.67%	12,160 $1.11 Million
Q2 2023 Jul 31, 2023	SELL	$155.98 - $172.65 $22,929 - $25,379	-147 Reduced 2.39%	6,000 $970,000
Q1 2023 Apr 20, 2023	BUY	$132.34 - $159.14 $13,498 - $16,232	102 Added 1.69%	6,147 $978,000
Q4 2022 Jan 31, 2023	BUY	$102.55 - $135.33 $20,202 - $26,660	197 Added 3.37%	6,045 $818,000
Q3 2022 Oct 24, 2022	SELL	$95.28 - $116.93 $14,006 - $17,188	-147 Reduced 2.45%	5,848 $583,000
Q2 2022 Jul 28, 2022	BUY	$103.24 - $121.81 $12,079 - $14,251	117 Added 1.99%	5,995 $668,000
Q1 2022 Apr 27, 2022	BUY	$93.1 - $112.54 $23,833 - $28,810	256 Added 4.55%	5,878 $653,000
Q4 2021 Feb 04, 2022	BUY	$95.88 - $117.08 $55,131 - $67,321	575 Added 11.39%	5,622 $630,000
Q3 2021 Oct 18, 2021	BUY	$84.42 - $106.62 $13,169 - $16,632	156 Added 3.19%	5,047 $485,000
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $15,561 - $19,494	230 Added 4.93%	4,891 $410,000
Q1 2021 May 04, 2021	BUY	$67.06 - $75.82 $14,887 - $16,832	222 Added 5.0%	4,661 $314,000
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $447 - $516	7 Added 0.16%	4,439 $310,000
Q3 2020 Nov 05, 2020	SELL	$63.69 - $70.22 $382 - $421	-6 Reduced 0.14%	4,432 $308,000
Q2 2020 Jul 30, 2020	BUY	$58.54 - $67.94 $6,615 - $7,677	113 Added 2.61%	4,438 $291,000
Q1 2020 Apr 29, 2020	BUY	$49.46 - $64.78 $19,042 - $24,940	385 Added 9.77%	4,325 $260,000
Q4 2019 Jan 31, 2020	BUY	$49.86 - $58.26 $2,592 - $3,029	52 Added 1.34%	3,940 $231,000
Q3 2019 Oct 25, 2019	SELL	$47.54 - $53.43 $2,852 - $3,205	-60 Reduced 1.52%	3,888 $201,000
Q2 2019 Aug 20, 2019	BUY	$46.79 - $52.47 $184,726 - $207,151	3,948 New	3,948 $202,000

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Novo Nordisk A S Transaction History